J. W. Lenders, Q. Y. Duh, G. Eisenhofer, A. P. Gimenez-roqueplo, S. K. Grebe et al., Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, pp.99-1915, 2014.

C. Pacak, Preoperative management of the pheochromocytoma patient, J Clin Endocrinol Metab, pp.92-4069, 2007.

A. Prejbisz, J. W. Lenders, G. Eisenhofer, and A. Januszewicz, Cardiovascular manifestations of phaeochromocytoma, J Hypertens, vol.29, pp.2049-60, 2011.

A. Scholten, R. M. Cisco, M. R. Vriens, J. K. Cohen, E. J. Mitmaker et al., Pheochromocytoma Crisis Is Not a Surgical Emergency, J Clin Endocrinol Metab, vol.98, pp.581-91, 2013.

M. Lafont, C. Fagour, M. Haissaguerre, G. Darancette, T. Wagner et al., Per-operative Hemodynamic Instability in Normotensive Patients With Incidentally Discovered Pheochromocytomas, J Clin Endocrinol Metab, vol.100, pp.417-438, 2015.

P. A. Van-der-zee and A. De-boer, Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin, Neth J Med, vol.72, pp.190-201, 2014.

J. W. Lenders, G. Eisenhofer, M. Mannelli, and P. K. Phaeochromocytoma, Lancet, vol.366, pp.665-75, 2005.

P. Gosse, P. Tauzin-fin, M. Sesay, A. Sautereau, and P. Ballanger, Preparation for surgery of phaeochromocytoma by blockade of a-adrenergic receptors with urapidil: what dose?, J Hum Hypertens, vol.23, pp.605-614, 2009.

M. Doolay and K. I. Doa, Urapidil: a reappraisal of its use in the management of hypertension, Drugs, vol.56, pp.929-55, 1998.

T. Nishiyama, T. Matsukawa, R. Hanaoka, and C. Conway, Interactions between nicardipine and enflurae, isoflurazne and sevorane, Can J Anaesth, vol.44, pp.1071-1077, 1997.

R. Ramachandran and V. Rewari, Current perioperative management of pheochromocytomas

, Indian J Urol, vol.33, pp.19-25, 2017.

J. Naranjo, S. Dodd, and Y. N. Martin, Peroperative management of pheochromocytoma, J Cardiothorac vasc Anesth, vol.3, pp.1427-1466, 2017.

A. N. Van-der-horst-schrivers, M. N. Kerstens, and B. H. Wolffenbuttel, Preoperative pharmacological management of phaeochromocytoma, Neth J Med, vol.64, pp.290-295, 2006.

N. Habbe, F. Ruger, J. Bojunga, W. O. Bechstein, and K. Holzer, Urapidil in the preoperative treatment for pheochromocytoma: a safe and cost-effective method, World J Surg, vol.37, pp.1141-1187, 2013.

S. Kocak, S. Aydintug, and N. Canakci, Alpha blockade in preoperative preparation of patients with pheochromocytoma, Int Surg, vol.87, pp.191-195, 2002.

R. Agrawal, S. K. Mishra, E. Bhatia, A. Mishra, G. Chand et al., Prospective Study to Compare Peri-operative Hemodynamic Alterations following Preparation for Pheochromocytoma Surgery by Phenoxybenzamine or Prazosin, World J Surg, vol.38, pp.716-739, 2014.

R. W. Randle, C. J. Balentine, S. C. Pitt, D. F. Schneider, and R. S. Sipple, Selective versus nonselective ? blockade prior to laparoscopic adrenalectomy for pheochromocytoma, Ann Surg Oncol, vol.24, pp.244-50, 2017.

A. Toniato, I. M. Boschin, G. Opocher, A. Guolo, M. Pelizzo et al., Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment?, Surgery, vol.141, pp.723-730, 2007.

W. Wang, P. Li, Y. Wang, Y. Wang, Z. Ma et al., Effectiveness and safety of laparoscopic adrenalectomy of large pheochromocytoma: a prospective, nonrandomized, controlled study, Am J Surg, vol.210, pp.230-235, 2015.

H. Bruynzeel, R. A. Feelders, T. H. Groenland, A. H. Van-den-meiracker, C. H. Van-eijck et al., Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma, J Clin Endocrinol Metab, vol.95, pp.678-85, 2010.

S. Y. Kwon, K. S. Lee, J. N. Lee, Y. S. Ha, S. H. Choi et al., Risk factors for hypertensive attack during pheochromocytoma resection, Investig Clin Urol, vol.57, pp.184-90, 2016.

P. Tauzin-fin, G. Hilbert, M. Krol-houdek, P. Gosse, and P. Maurette, Mydriasis and acute pulmonary oedema complicating laparoscopic removal of phaeochromocytoma, Anaesth Intensive Care, vol.27, pp.646-655, 1999.

B. C. Whitelaw, J. K. Prague, O. G. Mustafa, K. M. Schulte, P. A. Hopkins et al., Phaeochromocytoma crisis, Clinical Endocrinology, vol.0, pp.1-10, 2013.

P. Tauzin-fin, M. Sesay, P. Gosse, and P. Ballanger, Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma, Br J Anaesth, vol.92, pp.512-519, 2004.

, Hypertensive events in adults. High blood pressure without organ involvement and hypertensive events requiring emergency care. Guidelines, J Mal Vasc, vol.27, pp.234-242, 2002.

. Lenders, Q. Y. Duh, G. Eisenhofer, A. P. Gimenez-roqueplo, S. K. Grebe et al., Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline, J Clin Endocrinol Metab, vol.99, pp.1915-1957, 2014.

C. Pacak, Preoperative management of the pheochromocytoma patient, J Clin Endocrinol Metab, vol.92, pp.4069-79, 2007.

E. L. Bravo and R. Tagle, Pheochromocytoma: state-of-the-art and future prospects, Endoc Rev, vol.24, pp.539-53, 2003.

G. Eisenhofer, G. Rivers, A. L. Rosas, Z. Quezado, W. M. Manger et al., Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management, Drug Saf, vol.30, pp.1031-62, 2007.

R. Sheinberg, W. D. Gao, G. Wand, S. Abraham, R. Schulick et al., Case 1-2012 A Perfect Storm: Fatality Resulting From Metoclopramide Unmasking A Pheochromocytoma and Its Management, J Cardiothorac Vasc Anesth, vol.26, pp.161-51, 2012.

J. Lenders, K. Pacak, and M. M. Walther, Biochemical Diagnosis of Pheochromocytoma Which Test Is Best?, JAMA, vol.287, pp.1427-1434, 2002.

D. Taieb, F. Sebag, J. G. Hubbard, O. Mundler, J. F. Henry et al., Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?, Clin Endocrinol, vol.61, pp.102-110, 2004.

A. Prejbisz, J. W. Lenders, G. Eisenhofer, and A. Januszewicz, Cardiovascular manifestations of phaeochromocytoma, J Hypertens, vol.29, pp.2049-60, 2011.

M. A. Kinney, M. E. Warner, and J. A. , Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection, Anesth Analg, vol.91, pp.1118-1123, 2000.

C. Prys-roberts, Phaeochromocytoma -Recent progress in its management, Br J Anaesth, vol.85, pp.44-57, 2000.

A. Scholten, R. M. Cisco, M. R. Vriens, J. K. Cohen, E. J. Mitmaker et al.,

, Pheochromocytoma Crisis Is Not a Surgical Emergency, J Clin Endocrinol Metab, vol.98, pp.581-91, 2013.

M. Lafont, C. Fagour, M. Haissaguerre, G. Darancette, T. Wagner et al., Peroperative Hemodynamic Instability in Normotensive Patients With Incidentally Discovered Pheochromocytomas, J Clin Endocrinol Metab, vol.100, pp.417-438, 2015.

N. Weingarten, J. P. Cata, J. F. O'hara, D. J. Pr-illa, L. Pike et al., Comparison of Two Preoperative Medical Management Strategies for Laparoscopic Resection of Pheochromocytoma, Urology, vol.76, pp.508-514, 2010.

R. W. Randle, C. J. Balentine, S. C. Pitt, D. F. Schneider, and R. S. Sippel, Selective versus nonselective ?-blockade prior to laparoscopic adrenalectomy for pheochromocytoma, Ann Surg Oncol, vol.24, pp.244-50, 2017.

J. Li and C. H. Yang, Improvement of preoperative management in patients with adrenal pheochromocytoma, Int J Clin Exp Med, vol.7, pp.5541-5546, 2014.

C. M. Kiernan, L. Du, X. Chen, J. T. Broome, C. Shi et al., Predictors of Hemodynamic Instability During Surgery for Pheochromocytoma, Ann Surg Oncol, vol.21, pp.3865-71, 2014.

P. A. Van-der-zee and A. De-boer, Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin, Neth J Med, vol.72, pp.190-201, 2014.

H. Bruynzeel, R. A. Feelders, T. Groenland, A. H. Van-den-meiracker, C. Van-eijck et al., Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma, J Clin Endocrinol Metab, vol.95, pp.678-85, 2010.

G. Lebuffe, E. D. Dosseh, G. Tek, H. Tytgat, S. Moreno et al., The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas: CCBs effects in phaeochromocytoma or paraganglioma surgery, Anaesthesia, vol.60, pp.439-483, 2005.

A. G. Ramage, The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors, Br J Pharmacol, vol.102, pp.998-1002, 1991.

P. Gosse, P. Tauzin-fin, M. Sesay, A. Sautereau, and P. Ballanger, Preparation for surgery of phaeochromocytoma by blockade of a-adrenergic receptors with urapidil: what dose?, J Hum Hypertens, vol.23, pp.605-614, 2009.

C. Prys-roberts and J. R. Farndon, Efficacy and Safety of Doxazosin for Perioperative Management of Patients with Pheochromocytoma, World J Surg, vol.26, pp.1037-1079, 2002.

N. Habbe, F. Ruger, J. Bojunga, W. O. Bechstein, and K. Holzer, Urapidil in the Preoperative Treatment of Pheochromocytomas: A Safe and Cost-effective Method, World J Surg, vol.37, pp.1141-1147, 2013.

Y. Zhu, H. He, T. Su, Y. Wu, W. Wang et al., Selective ?1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma, Endocrine, vol.38, pp.254-263, 2010.

S. Kocak, S. Aydintug, and N. Canakci, Alpha blockade in preoperative preparation of patients with pheochromocytoma, Int Surg, vol.87, pp.191-195, 2002.

M. Doolay and K. I. Doa, Urapidil: a reappraisal of its use in the management of hypertension, Drugs, vol.56, pp.929-55, 1998.

T. Nishiyama, T. Matsukawa, R. Hanaoka, and C. Conway, Interactions between nicardipine and enflurane, isoflurane and sevoflurane, Can J Anaesth, vol.44, pp.1071-1077, 1997.

A. Toniato, I. M. Boschin, G. Opocher, A. Guolo, M. Pelizzo et al., Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment?, Surgery, vol.141, pp.723-730, 2007.

R. Agrawal, S. K. Mishra, E. Bhatia, A. Mishra, G. Chand et al., Prospective Study to Compare Peri-operative Hemodynamic Alterations following Preparation for Pheochromocytoma Surgery by Phenoxybenzamine or Prazosin, World J Surg, vol.38, pp.716-739, 2014.

H. H. Kim, G. H. Kim, and G. T. Sung, Laparoscopic Adrenalectomy for Pheochromocytoma: Comparison with Conventional Open Adrenalectomy, J Endourol, vol.18, pp.251-256, 2004.

W. Wang, P. Li, Y. Wang, Y. Wang, Z. Ma et al., Effectiveness and safety of laparoscopic adrenalectomy of large pheochromocytoma: a prospective, nonrandomized, controlled study, Am J Surg, vol.210, pp.230-235, 2015.

S. Y. Kwon, K. S. Lee, J. N. Lee, Y. Ha, S. H. Choi et al., Risk factors for hypertensive attack during pheochromocytoma resection, Investig Clin Urol, vol.57, p.184, 2016.

. Tauzin-fin-p-1, G. Hilbert, M. Krol-houdek, P. Gosse, and P. Maurette, Mydriasis and acute pulmonary oedema complicating laparoscopic removal of phaeochromocytoma

, Anaesth Intensive Care, vol.27, pp.646-655, 1999.

P. Tauzin-fin, M. Sesay, A. Quinart, P. Gosse, and F. Sztark, Acute coronary syndrome and sinus node arrest complicating preoperative management of pheochromocytoma, J Anaesthesiol Clin Pharmacol, vol.31, pp.431-433, 2015.

B. C. Whitelaw, J. K. Prague, and O. G. Mustafa, Phaeochromocytoma crisis, Clin Endocrinol, vol.80, pp.13-22, 2014.

P. Tauzin-fin, M. Sesay, P. Gosse, and P. Ballanger, Effects of perioperative ?1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma, Br J Anaesth, vol.92, pp.512-519, 2004.

, Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)

, High blood pressure without organ involvement and hypertensive events requiring emergency care. Guidelines, J Mal Vasc, vol.27, pp.234-242, 2002.

V. Billard, M. Cheikh, S. Delaporte-cerceau, and M. Raffin-sanson, Anesthésie pour traitement des tumeurs endocrines, Ann Fr Anesth Réanim, vol.28, pp.549-63, 2009.

C. Lentschener, S. Gaujoux, J. M. Thillois, D. Duboc, J. Bertherat et al., Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaeochromocytoma, Acta Anaesthesiol Scand, vol.53, pp.522-529, 2009.

C. Lents-hener and S. Gaujoux, Pas e traitement h potenseur ni 'expansion vol mi ue systématique pour tous les patients opérés de surrénalectomie pour phéochromocytome

, Ann Fr Anesth Réanim, vol.29, pp.60-61, 2010.

C. Lentschener, S. Gaujoux, A. Tesniere, and B. Dousset, Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal?, Eur J Endocrinol, vol.165, pp.365-73, 2011.